ROBYN BRIDGES: Open Payments
NPI 1841239589 · HIGH POINT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$651 in 28 payments from 9 companies in 2025. Trend: 2023 $987 · 2024 $788 · 2025 $651
Food & beverage: $651
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 9 | $182 |
| Bausch Health US, LLC | 6 | $115 |
| Alkermes, Inc. | 1 | $98 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| ABBVIE INC. | 2 | $42 |
| Janssen Pharmaceuticals, Inc | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: ABILIFY MAINTENA, APLENZIN, LYBALVI, CAPLYTA, ABILIFY ASIMTUFII, REXULTI, TRINTELLIX, VRAYLAR.
Industry payments across NC — which companies pay providers there.
